Pages that link to "Q44469084"

The following pages link to Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism (Q44469084):

Displaying 14 items.

• A new oral testosterone undecanoate formulation (Q33973411) (← links)
• Emerging medication for the treatment of male hypogonadism (Q34276286) (← links)
• Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis (Q34578805) (← links)
• Crucial role of androgen receptor in vascular H2S biosynthesis induced by testosterone (Q35204849) (← links)
• Androgen replacement therapy: present and future (Q35871132) (← links)
• Emerging drugs for hypogonadism (Q36634275) (← links)
• The latest options and future agents for treating male hypogonadism (Q37000744) (← links)
• Time for international action on treating testosterone deficiency syndrome (Q37162010) (← links)
• Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health (Q37733627) (← links)
• The andrologist's contribution to a better life for ageing men: part 1. (Q40513531) (← links)
• Effects of short-term testosterone replacement on areal bone mineral density and bone turnover in young hypogonadal males (Q41977168) (← links)
• Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus (Q45764744) (← links)
• Maldaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis (Q80406505) (← links)
• Vitamin D levels and bone mineral density: are LH levels involved in the pathogenesis of bone impairment in hypogonadal men? (Q85815516) (← links)